Profile data is unavailable for this security.
About the company
Quoin Pharmaceuticals Ltd, former Cellect Biotechnology Ltd, is an Israel-based specialty pharmaceutical company, focused on developing and commercializing therapeutic products that treat rare and orphan diseases. The Company’s first lead product is QRX003, a once daily, topical lotion comprised of a broad-spectrum serine protease inhibitor, formulated with the proprietary Invisicare technology, to treat Netherton Syndrome. The product going to be developed for other rare dermatological diseases including Peeling Skin Syndrome, SAM Syndrome, and Palmoplantar Keratoderma. Quoin is also developing QRX004 as a potential treatment for Dystrophic Epidermolysis Bullosa, and QRX006 as a potential therapy for an, as of yet, undisclosed rare skin disease.
- Revenue in USD (TTM)0.00
- Net income in USD-13.77m
- Incorporated1986
- Employees3.00
- LocationQuoin Pharmaceuticals Ltd23 Hata'as StreetKFAR SABA 44425IsraelISR
- Phone+972 99741444
- Fax+972 97678750
- Websitehttps://quoinpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inotiv Inc | 514.03m | -69.37m | 12.34m | 1.95k | -- | 0.1132 | -- | 0.024 | -2.02 | -2.02 | 15.00 | 3.17 | 0.6821 | 10.37 | 7.71 | 264,281.20 | -9.21 | -18.23 | -16.14 | -23.64 | 23.49 | 26.43 | -13.50 | -27.50 | 0.2218 | -0.6298 | 0.7918 | -- | 4.54 | 53.36 | 36.72 | -- | 21.79 | -- |
| Phio Pharmaceuticals Corp | 0.00 | -7.95m | 12.38m | 5.00 | -- | 0.6761 | -- | -- | -2.73 | -2.73 | 0.00 | 1.70 | 0.00 | -- | -- | 0.00 | -91.57 | -73.65 | -107.58 | -86.34 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 33.96 | -- | -57.49 | -- |
| BioCardia Inc | 0.00 | -8.54m | 12.63m | 17.00 | -- | 4.81 | -- | -- | -1.73 | -1.73 | 0.00 | 0.2476 | 0.00 | -- | -- | 0.00 | -137.58 | -102.48 | -272.63 | -150.23 | -- | -- | -- | -1,938.01 | -- | -- | 0.00 | -- | -87.84 | -39.41 | 31.33 | -- | -47.18 | -- |
| Hookipa Pharma Inc | 9.35m | -73.31m | 12.70m | 82.00 | -- | 0.3648 | -- | 1.36 | -5.85 | -5.85 | 0.7457 | 2.82 | 0.0903 | -- | 1.74 | 114,036.60 | -70.79 | -40.82 | -91.08 | -50.56 | -- | -- | -784.01 | -266.20 | -- | -- | 0.00 | -- | 118.32 | 29.77 | 46.67 | -- | -37.28 | -- |
| Bioatla Inc | 0.00 | -64.71m | 12.80m | 61.00 | -- | -- | -- | -- | -1.15 | -1.15 | 0.00 | -0.5313 | 0.00 | -- | -- | 0.00 | -165.61 | -49.22 | -317.99 | -57.35 | -- | -- | -- | -3,690.17 | -- | -- | -- | -- | -- | 16.17 | 43.48 | -- | -- | -- |
| NewcelX AG | 0.00 | -6.21m | 12.90m | 1.00 | -- | 0.4169 | -- | -- | -20.39 | -20.39 | 0.00 | 6.94 | 0.00 | -- | -- | 0.00 | -78.31 | -232.34 | -- | -- | -- | -- | -- | -- | -- | -53.01 | 0.00 | -- | -- | -- | 66.67 | -- | -- | -- |
| Kairos Pharma Ltd | 0.00 | -5.06m | 13.11m | 1.00 | -- | 1.71 | -- | -- | -0.3045 | -0.3045 | 0.00 | 0.3681 | 0.00 | -- | -- | 0.00 | -77.46 | -- | -92.07 | -- | -- | -- | -- | -- | -- | -94.05 | 0.00 | -- | -- | -- | -43.65 | -- | -- | -- |
| Traws Pharma Inc | 2.85m | 93.35m | 13.42m | 7.00 | 0.0595 | 2.64 | -- | 4.72 | 28.24 | 28.24 | 0.4566 | 0.6373 | 0.2662 | -- | 1.38 | 406,571.40 | -124.51 | -151.85 | -517.46 | -207.35 | -- | -- | -467.64 | -21,652.42 | -- | -- | 0.00 | -- | 0.00 | -36.47 | -188.55 | -- | -- | -- |
| Check Cap Ltd | 0.00 | -13.62m | 13.67m | 85.00 | -- | 2.92 | -- | -- | -2.33 | -2.33 | 0.00 | 0.6432 | 0.00 | -- | -- | -- | -114.23 | -61.64 | -130.02 | -67.99 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -43.15 | -- | -- | -- |
| Quoin Pharmaceuticals Ltd - ADR | 0.00 | -13.77m | 13.74m | 3.00 | -- | -- | -- | -- | -694.81 | -694.81 | 0.00 | -2.07 | 0.00 | -- | -- | 0.00 | -154.58 | -101.37 | -321.13 | -142.23 | -- | -- | -- | -- | -- | -- | 1.96 | -- | -- | -- | -3.18 | -- | -- | -- |
| Curis Inc | 11.65m | -36.56m | 14.15m | 33.00 | -- | -- | -- | 1.21 | -3.68 | -3.68 | 1.05 | -1.15 | 0.3323 | -- | 3.75 | 353,030.30 | -104.28 | -37.70 | -259.56 | -42.63 | 99.47 | 96.89 | -313.79 | -423.79 | -- | -- | -- | -- | 8.83 | 1.75 | 8.49 | -- | -- | -- |
| Cocrystal Pharma Inc | 0.00 | -9.67m | 14.20m | 11.00 | -- | 1.75 | -- | -- | -0.9356 | -0.9356 | 0.00 | 0.5881 | 0.00 | -- | -- | 0.00 | -72.50 | -43.29 | -83.33 | -45.24 | -- | -- | -- | -4,873.78 | -- | -- | 0.00 | -- | -- | -- | 2.67 | -- | -43.98 | -- |
| GT Biopharma Inc | 0.00 | -34.45m | 14.34m | 1.00 | -- | 2.01 | -- | -- | -3.93 | -3.93 | 0.00 | 0.2266 | 0.00 | -- | -- | 0.00 | -459.62 | -172.68 | -1,377.41 | -460.87 | -- | -- | -- | -- | -- | -3,105.50 | 0.00 | -- | -- | -- | -161.73 | -- | -- | -- |
Data as of Mar 04 2026. Currency figures normalised to Quoin Pharmaceuticals Ltd's reporting currency: US Dollar USD
94.95%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Ikarian Capital LLCas of 31 Jan 2026 | 211.54k | 25.21% |
| Stonepine Capital Management LLCas of 29 Jan 2026 | 93.46k | 11.14% |
| Woodline Partners LPas of 31 Dec 2025 | 79.58k | 9.49% |
| abrdn, Inc.as of 31 Dec 2025 | 75.00k | 8.94% |
| Millennium Management LLCas of 31 Dec 2025 | 74.82k | 8.92% |
| Summittx Capital LPas of 31 Dec 2025 | 64.80k | 7.72% |
| Boothbay Fund Management LLCas of 31 Dec 2025 | 59.84k | 7.13% |
| Adar1 Capital Management LLCas of 31 Dec 2025 | 58.23k | 6.94% |
| AIGH Capital Management LLCas of 31 Dec 2025 | 49.32k | 5.88% |
| Resolute Capital Asset Partners LLCas of 31 Dec 2025 | 30.00k | 3.58% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
